-
The lancet oncology · Jan 2017
CommentProgress in PARP inhibitors beyond BRCA mutant recurrent ovarian cancer?
- Antonio González Martín.
- MD Anderson Cancer Center Madrid, Madrid 28033, Spain. Electronic address: agonzalezm@seom.org.
- Lancet Oncol. 2017 Jan 1; 18 (1): 8-9.
no abstract available
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..